In summary, our study identifies that METTL3 promotes ccRCC progression through m6A modification-mediated translation of ABCD1, providing an epitranscriptional insight into the molecular mechanism in kidney cancer. The gene discussed is METTL3; the disease is nonpapillary renal cell carcinoma.